MX385254B - Uso de analogos de bimatoprost para el tratamiento de la reduccion de grasa corporal en un sujeto. - Google Patents

Uso de analogos de bimatoprost para el tratamiento de la reduccion de grasa corporal en un sujeto.

Info

Publication number
MX385254B
MX385254B MX2017013819A MX2017013819A MX385254B MX 385254 B MX385254 B MX 385254B MX 2017013819 A MX2017013819 A MX 2017013819A MX 2017013819 A MX2017013819 A MX 2017013819A MX 385254 B MX385254 B MX 385254B
Authority
MX
Mexico
Prior art keywords
fat reduction
bimatoprost
analogues
subject
treatment
Prior art date
Application number
MX2017013819A
Other languages
English (en)
Other versions
MX2017013819A (es
Inventor
David F Woodward
Jenny W Wang
Neil J Poloso
Robert M Burk
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of MX2017013819A publication Critical patent/MX2017013819A/es
Publication of MX385254B publication Critical patent/MX385254B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/559—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing hetero atoms other than oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

En este documento se describen métodos, compuestos y composiciones para la reducción de grasa, en particular para la reducción de grasa sin crecimiento significativo y/o adicional de pelo.
MX2017013819A 2015-04-30 2016-04-29 Uso de analogos de bimatoprost para el tratamiento de la reduccion de grasa corporal en un sujeto. MX385254B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562154926P 2015-04-30 2015-04-30
PCT/US2016/030251 WO2016176640A1 (en) 2015-04-30 2016-04-29 Cosmetic method and therapeutic use for fat reduction

Publications (2)

Publication Number Publication Date
MX2017013819A MX2017013819A (es) 2018-02-21
MX385254B true MX385254B (es) 2025-03-14

Family

ID=56072424

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017013819A MX385254B (es) 2015-04-30 2016-04-29 Uso de analogos de bimatoprost para el tratamiento de la reduccion de grasa corporal en un sujeto.

Country Status (15)

Country Link
US (2) US9795615B2 (es)
EP (2) EP3721885A1 (es)
JP (1) JP6796601B2 (es)
KR (1) KR102159427B1 (es)
CN (1) CN107660145B (es)
AU (1) AU2016254208B2 (es)
BR (1) BR112017023316A2 (es)
CA (1) CA2983942A1 (es)
CL (1) CL2017002726A1 (es)
IL (2) IL255318B (es)
MX (1) MX385254B (es)
RU (1) RU2017140078A (es)
SG (1) SG11201708827SA (es)
UA (1) UA120775C2 (es)
WO (1) WO2016176640A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2908731A1 (en) 2013-04-12 2014-10-16 Allergan, Inc. Sustained release of bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction
MX385254B (es) 2015-04-30 2025-03-14 Allergan Inc Uso de analogos de bimatoprost para el tratamiento de la reduccion de grasa corporal en un sujeto.
ES2995214T3 (en) 2019-03-06 2025-02-07 C4 Therapeutics Inc Heterocyclic compounds for medical treatment
US11452703B2 (en) 2020-05-21 2022-09-27 Peregrine Ophthalmic PTE LTD. Methods and compositions for reducing adipocyte numbers

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602900B2 (en) * 1992-09-21 2003-08-05 Allergan, Inc. Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US6124344A (en) 1993-12-28 2000-09-26 Allergan Sales, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
CA2221110C (en) * 1995-05-18 2009-08-04 Allergan Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension
US5741810A (en) * 1996-02-29 1998-04-21 Allergan Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
WO2007111806A2 (en) 2006-03-23 2007-10-04 Massachusetts Eye And Ear Infirmary Cyclopentane heptanoic acid compounds for reducing body fat
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
FR2920309B1 (fr) * 2007-08-28 2010-05-28 Galderma Res & Dev Utilisation de travoprost pour traiter la chute des cheveux
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
WO2011109384A2 (en) 2010-03-02 2011-09-09 Allergan, Inc. Biodegradable polymers for lowering intraocular pressure
CN108938441A (zh) * 2012-03-21 2018-12-07 宾夕法尼亚大学理事会 用于调节毛发生长的组合物和方法
RU2015134772A (ru) * 2013-03-15 2017-04-21 Аллерган, Инк. Применение биматопроста для повышения выработки лептина
CA2908731A1 (en) * 2013-04-12 2014-10-16 Allergan, Inc. Sustained release of bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction
NO2753788T3 (es) * 2013-05-10 2018-06-16
WO2015200425A1 (en) * 2014-06-27 2015-12-30 Topokine Therapeutics, Inc. Topical dosage regimen
MX385254B (es) 2015-04-30 2025-03-14 Allergan Inc Uso de analogos de bimatoprost para el tratamiento de la reduccion de grasa corporal en un sujeto.

Also Published As

Publication number Publication date
RU2017140078A (ru) 2019-05-30
UA120775C2 (uk) 2020-02-10
CA2983942A1 (en) 2016-11-03
IL255318B (en) 2021-05-31
SG11201708827SA (en) 2017-11-29
IL282473A (en) 2021-06-30
EP3721885A1 (en) 2020-10-14
EP3288559A1 (en) 2018-03-07
US20180071308A1 (en) 2018-03-15
US10117877B2 (en) 2018-11-06
CN107660145A (zh) 2018-02-02
CN107660145B (zh) 2021-04-20
EP3288559B1 (en) 2020-06-24
US20160317550A1 (en) 2016-11-03
US9795615B2 (en) 2017-10-24
BR112017023316A2 (pt) 2018-08-14
IL255318A0 (en) 2017-12-31
KR20170141770A (ko) 2017-12-26
AU2016254208A1 (en) 2017-11-16
RU2017140078A3 (es) 2019-08-06
WO2016176640A1 (en) 2016-11-03
KR102159427B1 (ko) 2020-09-24
AU2016254208B2 (en) 2021-07-15
JP6796601B2 (ja) 2020-12-09
CL2017002726A1 (es) 2018-05-04
JP2018514554A (ja) 2018-06-07
HK1250483A1 (zh) 2018-12-21
MX2017013819A (es) 2018-02-21

Similar Documents

Publication Publication Date Title
MX2022014331A (es) Metodos y composiciones para el tratamiento de trastornos epilepticos.
CL2021000855A1 (es) Replicones basados en alfavirus para la administración de bioterapias.
MX2024008096A (es) Mavacamten para su uso en el tratamiento de la cardiomiopatia hipertrofica.
MX2018014154A (es) Polinucleotidos moduladores.
BR112017024899A2 (pt) proteínas de ligação trispecíficas e métodos de uso.
PL3658140T3 (pl) Połączenia aprocitentanu z dodatkowymi składnikami czynnymi do leczenia opornego nadciśnienia
BR112018005892A2 (pt) composições para higiene bucal e métodos de uso.
PT3562486T (pt) Uso de dexmedetomidina sublingual para o tratamento da agitação
ECSP17063327A (es) Receptores de antígeno quiméricos anti–dll3 y métodos de uso
BR112016030968A2 (pt) análogos de pridopidina, preparação e uso destes
MX2021013476A (es) Composiciones de pienso para animales y uso de las mismas.
BR112018005753A2 (pt) composições para higiene bucal e métodos de uso.
CR20160362A (es) Anticuerpos anti-jagged1 y metodos de uso
ZA201707494B (en) Hair regrowth treatment and growth stimulant
BR112016030983A2 (pt) composições para o tratamento de obesidade, prevenção de ganho de peso, promoção de perda de peso, promoção de emagrecimento, ou tratamento de ou prevenção do desenvolvimento de diabetes, kit, método para a preparação de tirfostina 9 e uso
MX2018012285A (es) Metodos de tratamiento para enfermedades colestasicas y fibroticas.
LT3592355T (lt) Kx2-391/kx-01, skirtas naudoti aktininės keratozės gydymui
EA201992352A1 (ru) Фунгицидные комбинации
MX385254B (es) Uso de analogos de bimatoprost para el tratamiento de la reduccion de grasa corporal en un sujeto.
EP3773539A4 (en) COMPOSITIONS FOR THE TREATMENT OF THE SKIN
BR112018006560A2 (pt) composições para higiene bucal e métodos de uso das composições.
CL2018003143A1 (es) Compuesto de dihidroisoxazol para uso en el control de piojos de mar
ES1179484Y (es) Replica de implante dental digitalizable para implantologia dental
MX2018007128A (es) Composiciones para barnices dentales y metodos para su elaboracion y uso.
EP3790876C0 (en) ENDOPARASITIC DEPSIPEPTIDES